Trial Profile
A clinical study of G-100 in combination with rituximab in earlier-stage follicular lymphoma patients
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 21 Oct 2018
Price :
$35
*
At a glance
- Drugs Glycopyranosyl lipid adjuvant (Primary) ; Rituximab (Primary)
- Indications Follicular lymphoma
- Focus Therapeutic Use
- 21 Oct 2018 New trial record